China home to 200 mln hypertensive patients

China has more than 200 million hypertensive patients, according to Ma Xiaowei, an official at the National Health and Family Planning Commission of China.

China home to 200 mln hypertensive patients
NHFPC to Tighten Control over New Drugs Included into EDL and Open up Use of Non-EDL Drugs at the Grassroots Level

Today, National Health and Family Planning Commission (“NHFPC”) issued Circular on Further Enhancing the Management of Drugs use at Grassroots Medical Institutions, which explicitly stated that new drugs are not encouraged to enlist into Essential Drug List (“EDL”)

The Current Status and Research Forecast of Diabetic Drugs Analysis

Following is a brief summary and prospect of these new progresses.

China Approves its First Anti-Ebola Drug

“jk-05”, the new drug designated to treat Ebola has passed the evaluation by health experts at the People’s Liberation Army General Medical Department.

Zhejiang to Enhance Drug Tendering Management and Control

Recently, many provinces including Sichuan and Jiangxi have begun a new round of drug tendering.

Chinese Pharmaceutical Manufacturing Industry Recorded Steady But Slower Growth in the First Half of 2014

The interim results of the major listed pharmaceutical companies showed that the whole pharmaceutical industry has maintained a steady and slower year-on-year growth. In the first half of 2014

Total 17 Pages  First page  Page up  Page down  Last page


  • 2014
  • 2013
  • 2012